93 related articles for article (PubMed ID: 4096744)
1. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
[TBL] [Abstract][Full Text] [Related]
2. Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine.
Randi ML; Mares M; Fabris F; Tison T; Barbone E; Girolami A
Arzneimittelforschung; 1991 Apr; 41(4):414-6. PubMed ID: 1859515
[TBL] [Abstract][Full Text] [Related]
3. Effects of ticlopidine on platelet function and blood coagulation.
Violi F; Alessandri C; Frattaroli S; Ghiselli A; Balsano F
Thromb Haemost; 1982 Oct; 48(2):166-8. PubMed ID: 6217577
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and blood rheologic effects of ticlid in patients with cerebrovascular diseases].
Suslina ZA; Ionova VG; Nikitenko NIu; Maksimova MIu
Ter Arkh; 1993; 65(9):53-6. PubMed ID: 8303598
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
[TBL] [Abstract][Full Text] [Related]
6. Effect of buflomedil, dipyridamole and indobufene on hemorrheologic and blood coagulation parameters in patients who underwent vascular surgery for severe atherosclerosis.
Mares M; Sogaro F; Scomparin MA; Boeri G; Cella G
J Med; 1991; 22(3):163-9. PubMed ID: 1770324
[TBL] [Abstract][Full Text] [Related]
7. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
Lee H; Paton RC; Ruan C; Caen JP
Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
[No Abstract] [Full Text] [Related]
9. [Effect of balneotherapeutic measures on blood rheologic parameters in patients with atherosclerosis].
Winkler R; Klieber M
Wien Klin Wochenschr; 1986 Aug; 98(15):490-5. PubMed ID: 3765637
[TBL] [Abstract][Full Text] [Related]
10. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
11. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
de Maat MP; Arnold AE; van Buuren S; Wilson JH; Kluft C
Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
[TBL] [Abstract][Full Text] [Related]
12. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.
Kirstein P; Jogestrand T; Johnsson H; Olsson AG
Atherosclerosis; 1980 Aug; 36(4):471-80. PubMed ID: 7417366
[TBL] [Abstract][Full Text] [Related]
13. Decrease of platelet intracellular pH and adhesion by ticlopidine in patients with vascular disease.
Lechi C; Gaino S; Andrioli G; Paluani F; Guzzo P; Bellavite P; Zatti M; Arosio E
Int Angiol; 1998 Mar; 17(1):38-42. PubMed ID: 9657246
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis.
Ciuffetti G; Lombardini R; Pirro M; Lupattelli G; Mannarino E
Clin Hemorheol Microcirc; 2001; 25(1):31-9. PubMed ID: 11790868
[TBL] [Abstract][Full Text] [Related]
15. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
[TBL] [Abstract][Full Text] [Related]
16. [Study of blood viscosity and fibrinogen as a guide to the therapy of atherosclerotic peripheral arteriopathy].
Savi I; Pola P
Minerva Med; 1978 Dec; 69(63):4401-10. PubMed ID: 745806
[TBL] [Abstract][Full Text] [Related]
17. [Thrombocytopenia due to antibodies induced by ticlopidine].
Claas FH; de Fraiture WH; Meyboom RH
Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
[TBL] [Abstract][Full Text] [Related]
18. The effects of xanthinol nicotinate on the small blood vessels.
Davis E; Rozov H
Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
[No Abstract] [Full Text] [Related]
19. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
[TBL] [Abstract][Full Text] [Related]
20. A comparison of ticlopidine and heparin on hemodialysis in dogs.
Gross ML; Bush H; Weinger R; Hamburger RJ; Flamenbaum W
J Lab Clin Med; 1982 Dec; 100(6):887-95. PubMed ID: 7142790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
